Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial

Have we now reached the point where it would be unethical not to apply ePROs systematically to routine clinical #cancer care?

RT @PRO_ON_Dk: Electronic self-reporting of AEs during #immunotherapy significantly improves #HRQoL in patients with #Melanoma compared to…

Fantastic work, congratulations @TolstrupL @cancer_dk

Electronic self-reporting of AEs during #immunotherapy significantly improves #HRQoL in patients with #Melanoma compared to controls. Important results from a Danish RCT @TolstrupL @Helle_PP @KDieperink https://t.co/DGTuGMCBMl

RT @JPRO_ISOQOL: Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related qual…

Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial https://t.co/MFPmFXdSzd

Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial https://t.co/MXS6Ckymme

New article: Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial https://t.co/QKKKJkYFjE #melanoma #oncology https://